Remember, aim for the side wall and inject slowly
[DOI] [PMC free article] [PubMed] [Google Scholar] 102.Pooled analyses of phase III studies of ADS-5102 (amantadine) extended-release capsules for dyskinesia in Parkinson's disease
However, due to the risk of sequelae in younger patients in the NPMD, the alternative would be chemotherapy
Xing, J., et al
Factors such as Medicaid coverage, income levels, age, and healthcare infrastructure play a crucial role in determining who can currently benefit from these medications, and addressing these disparities will be key to maximizing access to GLP-1 therapies in the years ahead
The American Medical Association recommends PCAB-accredited pharmacies, specifically when providers are choosing a compounding partner, which is one of the few instances where a major medical organization has taken a position on this